This study has public registry information in the United States, in Bulgaria, in Colombia, .... It is testing an Investigational Drug for schizophrenia.

SchizophreniaOtherFrom 13 Years to 65 Years

Countries: United States, Bulgaria, Colombia, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

View study

CompletedNCT04038957

A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging

This study is completed in the United Kingdom. It focuses on schizophrenia.

SchizophreniaOtherFrom 18 Years to 45 Years

Countries: United Kingdom
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

View study

CompletedNCT04369391

A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia.

This study is completed. It focuses on schizophrenia and currently lists study information in the United States.

SchizophreniaOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

View study

CompletedNCT05848700

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

This study is completed. It focuses on schizophrenia and currently lists study information in the United States.

SchizophreniaOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

View study

CompletedNCT03543410

A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression

This study is completed in the United States, in Bulgaria, in Japan, .... It focuses on depression.

Depression, BipolarityOtherFrom 18 Years to 65 Years

Countries: United States, Bulgaria, Japan, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Depression, Bipolarity

View study

TerminatedNCT05753007

A study of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

This study has public registry information. It focuses on anxiety and currently lists study information in the United States.

AnxietyOtherOver 18 Years

Countries: United States
Sponsor: Mclean Hospital
Condition: Anxiety

View study

CompletedNCT03460756

A study of Oral Ganaxolone in Women With Postpartum Depression

This study is completed. It focuses on depression and currently lists study information in the United States.

DepressionOtherFrom 18 Years to 48 Years

Countries: United States
Sponsor: Marinus Pharmaceuticals
Condition: Depression

View study

Active Not RecruitingNCT05624528

A study of Tolcapone in Obsessive Compulsive Disorder

This study is active but not recruiting. It focuses on mental health and currently lists study information in the United States.

Mental healthOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Chicago
Condition: Mental health

View study

CompletedNCT04865835

A study Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.

This study is completed in the United States. It focuses on schizophrenia.

SchizophreniaOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

View study